Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Intelligent Observation has been recognized by MedTech Outlook Magazine as the exclusive recipient of “ Top 10 Infection Control Solutions Companies – 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Seth Freedman, CEO and Founder.

“The single most important, easiest, and least expensive means of complying with hygiene standards is ensuring that every healthcare worker washes or sanitizes their hands before and after attending to a patient,” says Seth Freedman, CEO and Founder of Intelligent Observation.![]()
The single most important, easiest, and least expensive means of complying with hygiene standards is ensuring that every healthcare worker washes or sanitizes their hands before and after attending to a patient



Company
Intelligent Observation
Management
Seth Freedman, CEO and Founder
Description
Intelligent Observation (IO) helps healthcare staff combat HAIs and create a safer hospital environment through its innovative electronic hand hygiene monitoring system. Leveraging its patented NFMI technology, IO precisely records every single hand hygiene compliance event in a healthcare facility.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
